XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCKHOLDERS' EQUITY | 9 Months Ended
--- | ---
Sep. 30, 2017
Stockholders' Equity Note [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY
Changes in Accumulated Other Comprehensive Income (Loss) The table below presents changes in AOCI by component for the three and nine months ended September 30, 2017 and 2016. All amounts are net of tax (in millions).
| Three Months Ended September 30, 2017 |  | Three Months Ended September 30, 2016
| CTA | Derivative Hedging Adj. | Debt & Equity Securities Adj. | Pension Liability Adj. | Total |  | CTA | Derivative Hedging Adj. | Debt & Equity Securities Adj. | Pension Liability Adj. | Total
Beginning balance | $ | (190.3 | ) | $ | 3.1 |  | $ | 1.3 |  | $ | (107.7 | ) | $ | (293.6 | ) |  | $ | (503.2 | ) | $ | (2.5 | ) | $ | (4.0 | ) | $ | (146.6 | ) | $ | (656.3 | )
Other comprehensive income (loss) before reclassifications | 32.4 |  | (0.1 | ) | 2.4 |  | (2.0 | ) | 32.7 |  |  | 2.1 |  | (1.1 | ) | (1.2 | ) | — |  | (0.2 | )
Amounts reclassified from AOCI | (1.2 | ) | (1.0 | ) | — |  | 1.5 |  | (0.7 | ) |  | 0.1 |  | 0.9 |  | — |  | 1.7 |  | 2.7 |
Net Other Comprehensive Income (Loss) | 31.2 |  | (1.1 | ) | 2.4 |  | (0.5 | ) | 32.0 |  |  | 2.2 |  | (0.2 | ) | (1.2 | ) | 1.7 |  | 2.5 |
Ending balance | $ | (159.1 | ) | $ | 2.0 |  | $ | 3.7 |  | $ | (108.2 | ) | $ | (261.6 | ) |  | $ | (501.0 | ) | $ | (2.7 | ) | $ | (5.2 | ) | $ | (144.9 | ) | $ | (653.8 | )
| Nine Months Ended September 30, 2017 |  | Nine Months Ended September 30, 2016
| CTA (1) | Derivative Hedging Adj. | Debt & Equity Securities Adj. | Pension Liability Adj. (2) | Total |  | CTA | Derivative Hedging Adj. | Debt & Equity Securities Adj. | Pension Liability Adj. | Total
Beginning balance | $ | (615.3 | ) | $ | (2.4 | ) | $ | 0.6 |  | $ | (162.3 | ) | $ | (779.4 | ) |  | $ | (492.7 | ) | $ | 2.3 |  | $ | (6.3 | ) | $ | (152.9 | ) | $ | (649.6 | )
Other comprehensive income (loss) before reclassifications | 100.4 |  | 3.7 |  | 3.0 |  | (5.5 | ) | 101.6 |  |  | (8.4 | ) | (4.7 | ) | 1.1 |  | 3.0 |  | (9.0 | )
Amounts reclassified from AOCI | 355.8 |  | 0.7 |  | 0.1 |  | 59.6 |  | 416.2 |  |  | 0.1 |  | (0.3 | ) | — |  | 5.0 |  | 4.8 |
Net Other Comprehensive Income (Loss) | 456.2 |  | 4.4 |  | 3.1 |  | 54.1 |  | 517.8 |  |  | (8.3 | ) | (5.0 | ) | 1.1 |  | 8.0 |  | (4.2 | )
Ending balance | $ | (159.1 | ) | $ | 2.0 |  | $ | 3.7 |  | $ | (108.2 | ) | $ | (261.6 | ) |  | $ | (501.0 | ) | $ | (2.7 | ) | $ | (5.2 | ) | $ | (144.9 | ) | $ | (653.8 | )
(1) Reclassification of $352.1 million of losses (net of $1.5 million of tax benefits) from AOCI to Gain (loss) on disposition of discontinued operations - net of tax in connection with the sale of the MHPS business during the nine months ended September 30, 2017. (2) Reclassification of AOCI during the nine months ended September 30, 2017 primarily relates to $55.4 million of losses (net of $23.9 million of tax benefits) reclassified from AOCI to Gain (loss) on disposition of discontinued operations - net of tax in connection with the sale of the MHPS business. Noncontrolling Interest During the nine months ended September 30, 2017, Noncontrolling interest decreased by $35.9 million primarily due to the divestiture of our MHPS segment in January of 2017. Stock-Based Compensation During the nine months ended September 30, 2017, the Company awarded 1.4 million shares of restricted stock to its employees with a weighted average grant date fair value of $32.34 per share. Approximately 63% of these restricted stock awards vest ratably over a three year period and approximately 37% cliff vest at the end of a three year period. Approximately 13% of the shares granted are based on performance targets containing a market condition determined over a three year period. The Company used the Monte Carlo method to determine grant date fair value of $36.48 per share for the awards with a market condition granted on March 2, 2017. The Monte Carlo method is a statistical simulation technique used to provide the grant date fair value of an award. The following table presents the weighted-average assumptions used in the valuation:
| Grant date
| March 2, 2017
Dividend yields | 1.01 | %
Expected volatility | 42.78 | %
Risk free interest rate | 1.55 | %
Expected life (in years) | 3 |
Share Repurchases and Dividends In February 2015, the Company announced authorization by its Board of Directors for the repurchase of up to $200 million of the Company’s outstanding shares of common stock of which approximately $131 million of this authorization was utilized prior to January 1, 2017. In February 2017, the Company announced authorization by its Board of Directors for the repurchase of up to an additional $350 million of the Company’s outstanding shares of common stock. In May 2017, the Company announced the completion of the February 2015 and February 2017 authorizations and subsequently that the Company’s Board of Directors had authorized the repurchase of up to an additional $280 million of the Company’s outstanding shares of common stock. In September 2017, the Company announced the completion of the May 2017 authorization and subsequently that the Company’s Board of Directors had authorized a new share repurchase program of up to $225 million of the Company’s outstanding shares of common stock. During the nine months ended September 30, 2017, the Company repurchased approximately 22.3 million shares for approximately $770.2 million under these programs. A portion of the share repurchases was executed prior to September 30, 2017 but cash settled in October. In each of the first three quarters of 2017, the Company’s Board of Directors declared a dividend of $0.08 per share, which was paid to its shareholders. On October 11, 2017 the Company’s Board of Directors declared a quarterly dividend of $0.08 per share, to be paid on December 19, 2017 to all stockholders of record as of the close of business on November 9, 2017.

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration